Bacteria As the Cause of Ulcerative Colitis

Overview

Journal Gut

Specialty Gastroenterology

Date 2000 Dec 15

PMID 11115835

Citations 65

Authors

M Campieri

P Gionchetti

Affiliations

Soon will be listed here.

Citing Articles

Comparison of microbial communities and the profile of sulfate-reducing bacteria in patients with ulcerative colitis and their association with bowel diseases: a pilot study.

Kushkevych I, Martinkova K, Mrakova L, Giudici F, Baldi S, Novak D Microb Cell. 2024; 11:79-89.

PMID: 38486888 PMC: 10939707. DOI: 10.15698/mic2024.03.817.

Microbial Modulation in Inflammatory Bowel Diseases.

Yu J, Cheon J Immune Netw. 2023; 22(6):e44.

PMID: 36627937 PMC: 9807960. DOI: 10.4110/in.2022.22.e44.

Ameliorative Effects of subsp. J-12 on Hyperglycemia in Pregnancy and Pregnancy Outcomes in a High-Fat-Diet/Streptozotocin-Induced Rat Model.

Yang J, Ma Y, Li T, Pang Y, Zhang H, Xie Y Nutrients. 2023; 15(1).

PMID: 36615827 PMC: 9824282. DOI: 10.3390/nu15010170.

Bioengineered Co-culture of organoids to recapitulate host-microbe interactions.

Kim M, Hwangbo S, Jang S, Jo Y Mater Today Bio. 2022; 16:100345.

PMID: 35847376 PMC: 9283667. DOI: 10.1016/j.mtbio.2022.100345.

Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity.

Mills R, Dulai P, Vazquez-Baeza Y, Sauceda C, Daniel N, Gerner R Nat Microbiol. 2022; 7(2):262-276.

PMID: 35087228 PMC: 8852248. DOI: 10.1038/s41564-021-01050-3.

References

Schultsz C, van den Berg F, ten Kate F, Tytgat G, Dankert J . The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology. 1999; 117(5):1089-97. DOI: 10.1016/s0016-5085(99)70393-8. View

Madsen K, Doyle J, Jewell L, Tavernini M, Fedorak R . Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology. 1999; 116(5):1107-14. DOI: 10.1016/s0016-5085(99)70013-2. View

TRUELOVE S, Jewell D . Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet. 1974; 1(7866):1067-70. DOI: 10.1016/s0140-6736(74)90552-2. View

Marcus R, Watt J . Ulcerative disease of the colon in laboratory animals induced by pepsin inhibitors. Gastroenterology. 1974; 67(3):473-83. View

Azad Khan A, Piris J, TRUELOVE S . An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet. 1977; 2(8044):892-5. DOI: 10.1016/s0140-6736(77)90831-5. View

Roediger W . The colonic epithelium in ulcerative colitis: an energy-deficiency disease?. Lancet. 1980; 2(8197):712-5. DOI: 10.1016/s0140-6736(80)91934-0. View

Cummings J . Short chain fatty acids in the human colon. Gut. 1981; 22(9):763-79. PMC: 1419865. DOI: 10.1136/gut.22.9.763. View

Simon G, Gorbach S . Intestinal flora in health and disease. Gastroenterology. 1984; 86(1):174-93. View

Dickinson R, OConnor H, Pinder I, Hamilton I, Johnston D, Axon A . Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis. Gut. 1985; 26(12):1380-4. PMC: 1433117. DOI: 10.1136/gut.26.12.1380. View

10.

Chapman R, Selby W, Jewell D . Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut. 1986; 27(10):1210-2. PMC: 1433885. DOI: 10.1136/gut.27.10.1210. View

11.

Onderdonk A, Bronson R, Cisneros R . Comparison of Bacteroides vulgatus strains in the enhancement of experimental ulcerative colitis. Infect Immun. 1987; 55(3):835-6. PMC: 260420. DOI: 10.1128/iai.55.3.835-836.1987. View

12.

Burke D, Axon A . Ulcerative colitis and Escherichia coli with adhesive properties. J Clin Pathol. 1987; 40(7):782-6. PMC: 1141098. DOI: 10.1136/jcp.40.7.782. View

13.

Burke D, Axon A . Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea. BMJ. 1988; 297(6641):102-4. PMC: 1833778. DOI: 10.1136/bmj.297.6641.102. View

14.

von Wulffen H, Russmann H, Karch H, Meyer T, Bitzan M, Kohrt T . Verocytotoxin-producing Escherichia coli O2:H5 isolated from patients with ulcerative colitis. Lancet. 1989; 1(8652):1449-50. DOI: 10.1016/s0140-6736(89)90151-7. View

15.

Burke D, Axon A, Clayden S, Dixon M, Johnston D, Lacey R . The efficacy of tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Ther. 1990; 4(2):123-9. DOI: 10.1111/j.1365-2036.1990.tb00456.x. View

16.

Sanderson J, Moss M, Tizard M, Hermon-Taylor J . Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut. 1992; 33(7):890-6. PMC: 1379400. DOI: 10.1136/gut.33.7.890. View

17.

Fabia R, ArRajab A, Johansson M, Willen R, Andersson R, Molin G . The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat. Scand J Gastroenterol. 1993; 28(2):155-62. DOI: 10.3109/00365529309096063. View

18.

Sutherland L, May G, Shaffer E . Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med. 1993; 118(7):540-9. DOI: 10.7326/0003-4819-118-7-199304010-00009. View

19.

Hollander D . Permeability in Crohn's disease: altered barrier functions in healthy relatives?. Gastroenterology. 1993; 104(6):1848-51. DOI: 10.1016/0016-5085(93)90668-3. View

20.

Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W . Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993; 75(2):263-74. DOI: 10.1016/0092-8674(93)80068-p. View